Abbott Laboratories (XSWX:ABT) Cash per Share: CHF3.30 (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Abbott Laboratories XSWX:ABT

What is Abbott Laboratories Cash per Share?

Abbott Laboratories XSWX:ABT +1.25% 78 Cash per Share is CHF3.30 as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 78/100 and a GF Value™ of CHF104.95.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Abbott Laboratories's Cash per Share for the quarter that ended in Mar. 2026 was CHF3.30.

Abbott Laboratories (XSWX:ABT) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Abbott Laboratories Cash per Share Related Terms

Abbott Laboratories Cash per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cash per Share Chart

Abbott Laboratories Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

5.35

5.45

3.63

4.10

Abbott Laboratories Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															3.48	3.40	3.54	4.10	3.30

78GF Score

Abbott Laboratories XSWX:ABT

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Abbott Laboratories Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Abbott Laboratories's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	7123.489	/	1,737
	=	4.10

Abbott Laboratories's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	5743.354	/	1,742
	=	3.30

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of CHF3.30 mean?

Abbott Laboratories (XSWX:ABT) has a Cash per Share of CHF3.30 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Abbott Laboratories and its competitors.

Is Abbott Laboratories' Cash per Share too high?

Abbott Laboratories' current Cash per Share is CHF3.30. Overall, Abbott Laboratories has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.

How does Abbott Laboratories' Cash per Share compare to SYK and MDT?

Abbott Laboratories' Cash per Share of CHF3.30 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Medical Devices & Instruments company?

A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Abbott Laboratories and its competitors. Abbott Laboratories's current Cash per Share is CHF3.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Abbott Laboratories stock overvalued right now?

Abbott Laboratories (XSWX:ABT) has a current Cash per Share of CHF3.30. The stock's GF Value™ is CHF104.95, compared to a current price of CHF81.00 — trading 22.8% below its estimated fair value. The current Cash per Share is CHF3.30. Abbott Laboratories' overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Cash per Share is CHF3.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF81.00 is trading 22.8% below its estimated GF Value™ of CHF104.95.

Key valuation signals for XSWX:ABT:

Cash per Share: CHF3.30
GF Value™: CHF104.95 vs. price of CHF81.00 (22.8% below fair value)
GF Score™: 78/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SYK MDT BSX EW GEHC DXCM STE ZBH PEN GMED XTER:SHL XAMS:PHIA SZSE:300760 XSWX:SOON LSE:SN.SHSE:688271 TSE:7733 PODD BRKR OCSE:DEMANT

Other Exchanges ABT:USA ABT:Peru ABT:Mexico 1ABT:Italy 0Q15:UK ABL:Germany ABT:Chile ABT:Canada ABTT34:Brazil ABL:Bulgaria ABT:Austria ABT:Argentina

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website https://www.abbott.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

78GF Score

Get the complete analysis for XSWX:ABT

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF81.00

Price

CHF104.95

GF Value

View XSWX:ABT Analysis

See Cash per Share data for all stocks →